The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Post-prostatectomy persisting PSA: Correlation with disease progression and survival in pT3 prostate cancer patients of the ARO 96-02 randomized phase III clinical trial—10 years' follow-up.
Thomas Wiegel
No relevant relationships to disclose
Detlef Bartkowiak
No relevant relationships to disclose
Dirk Bottke
No relevant relationships to disclose
Axel Hinke
No relevant relationships to disclose
Michael Stöckle
No relevant relationships to disclose
Manfred Wirth
No relevant relationships to disclose
Axel Semjonow
No relevant relationships to disclose
Kurt Miller
No relevant relationships to disclose